Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Corporate Crypto-Treasury Firms Under Pressure as BlackRock Pushes New Staked Ether Fund

Corporate Crypto-Treasury Firms Under Pressure as BlackRock Pushes New Staked Ether Fund

DeFi PlanetDeFi Planet2025/11/20 20:30
By:DeFi Planet

Quick Breakdown 

  • Corporate crypto-treasury firms face deep valuation pressures as their Ether holdings fall below cost basis.
  • BitMine Immersion Technologies holds $10.7B in ETH but sits on a $3.7B unrealized loss.
  • BlackRock’s move into staked Ether ETFs could intensify competition and threaten the economics of existing DATs.

Corporate treasuries struggle amid falling Ether valuations

Concerns are growing over the long-term sustainability of corporate crypto-treasury firms as the value of their Ether holdings continues to slide. A new report from 10x Research highlights steep unrealized losses across the sector, with many investors now stuck in positions they can’t exit without major losses.

Corporate Crypto-Treasury Firms Under Pressure as BlackRock Pushes New Staked Ether Fund image 0 Source: 10X Research  

BitMine Immersion Technologies, the largest corporate Ether holder, is bearing the biggest hit. The company is currently down around $1,000 per ETH, resulting in a cumulative unrealized loss of roughly $3.7 billion. BitMine holds about 3.56 million ETH, valued at approximately $10.7 billion, representing 2.94% of the total Ethereum supply. Its average cost basis stands at $4,051 per ETH.

10x Research founder Markus Thielen warned that the decline in net asset value is leaving shareholders in what he described as a “Hotel California scenario,” where investors are effectively trapped unless they accept steep losses. He argued that, unlike ETFs, digital-asset treasury firms (DATs) often layer on opaque, hedge-fund-like fees that quietly dilute returns.

mNAV declines signal capital raising challenges

The report also points to rapidly falling mNAV (market NAV) ratios, a key metric that compares a company’s enterprise value to the value of its crypto holdings. An mNAV above 1 enables companies to issue new shares to buy more digital assets , while values below 1 signal that securing fresh capital becomes harder.

BitMine’s basic mNAV is now 0.77, with a diluted mNAV of 0.92, indicating restricted room for expansion according to data from Bitminetracker. Other major DATs, including Strategy, Metaplanet, Sharplink Gaming, Upexi, and DeFi Development Corp, have seen similar declines.

BlackRock enters the arena with lower-cost staked Ether ETF

The challenges facing DATs are set to intensify as BlackRock steps deeper into the Ether market. The world’s largest asset manager has registered a new staked Ether ETF in Delaware, signalling a push toward Ethereum-based yield products.

BlackRock joins other asset managers, such as REX-Osprey and Grayscale, both of which launched staked ETH ETFs earlier this year.

 

Take control of your crypto  portfolio with MARKETS PRO, DeFi Planet’s suite of analytics tools.”

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

AI Sell-off Hits Anthropic IPO, Potential Valuation Expected to Drop to $1.2–1.3 Trillion

The valuation range discussed by potential investors has been lowered from the previous high of $2 trillion to between $1.2 trillion and $1.3 trillion, and some strategists have even suggested going below $1 trillion to ensure safety. In the face of significant market volatility and financial concerns such as quarterly losses, Anthropic is facing tough decisions, including a discounted valuation, reducing the size of the offering, or postponing the listing.

华尔街见闻•2026/11/06 13:42
AI Sell-off Hits Anthropic IPO, Potential Valuation Expected to Drop to $1.2–1.3 Trillion

Moderna Q3 revenue up 29% year-on-year, far exceeding expectations, raises full-year revenue growth guidance to 15%-25% | Earnings Report Insight

Moderna's Q3 revenue increased by 29% year-on-year to $1.31 billion, with profits significantly exceeding expectations. The company raised its 2026 revenue growth guidance to 15%-25%. The ramp-up of next-generation COVID-19 and flu vaccines, along with international market expansion, has driven performance improvement. Phase III data for the personalized cancer vaccine has also shown positive progress. The company is simultaneously advancing cost reduction and pipeline R&D, with year-end cash expectations significantly raised.

华尔街见闻•2026/11/06 13:23

Eli Lilly (LLY.US) "lowers its stance" and joins forces with former rival Hims (HIMS.US) to compete for the self-pay weight loss drug market

Eli Lilly is collaborating with Hims & Hers Health, leveraging the telehealth company’s large customer base to expand access to its blockbuster weight loss drugs and boost sales of medications, including its new oral weight loss drug Foundayo.

智通财经•2026/11/06 12:37
Eli Lilly (LLY.US) "lowers its stance" and joins forces with former rival Hims (HIMS.US) to compete for the self-pay weight loss drug market